Land Walter G, Linkermann Andreas
German Academy for Transplantation Medicine, Munich, Germany.
Laboratoire d'ImmunoRhumatologie Moléculaire, plateforme GENOMAX, INSERM UMR_S 1109, Faculté de Médecine, Fédération Hospitalo-Universitaire OMICARE, Fédération de Médecine Translationnelle de Strasbourg (FMTS), Institut Thématique Interdisciplinaire TRANSPLANTEX NG, Université de Strasbourg, Strasbourg, France.
Front Transplant. 2025 Apr 24;4:1571516. doi: 10.3389/frtra.2025.1571516. eCollection 2025.
This Part 1 of a bipartite review commences with a succinct exposition of innate alloimmunity in light of the danger/injury hypothesis in Immunology. The model posits that an alloimmune response, along with the presentation of alloantigens, is driven by DAMPs released from various forms of regulated cell death (RCD) induced by any severe injury to the donor or the donor organ, respectively. To provide a strong foundation for this review, which examines RCD and DAMPs as biomarkers and therapeutic targets in normothermic regional perfusion (NRP) and normothermic machine perfusion (NMP) to improve outcomes in organ transplantation, key insights are presented on the nature, classification, and functions of DAMPs, as well as the signaling mechanisms of RCD pathways, including ferroptosis, necroptosis, pyroptosis, and NETosis. Subsequently, a comprehensive discussion is provided on major periods of injuries to the donor or donor organs that are associated with the induction of RCD and DAMPs and precede the onset of the innate alloimmune response in recipients. These periods of injury to donor organs include conditions associated with donation after brain death (DBD) and donation after circulatory death (DCD). Particular emphasis in this discussion is placed on the different origins of RCD-associated DAMPs in DBD and DCD and the different routes they use within the circulatory system to reach potential allografts. The review ends by addressing another particularly critical period of injury to donor organs: their postischemic reperfusion following implantation into the recipient-a decisive factor in determining transplantation outcome. Here, the discussion focuses on mechanisms of ischemia-induced oxidative injury that causes RCD and generates DAMPs, which initiate a robust innate alloimmune response.
本二分法综述的第 1 部分首先根据免疫学中的危险/损伤假说来简要阐述先天性同种异体免疫。该模型假定,同种异体免疫反应以及同种异体抗原的呈递是由分别由供体或供体器官的任何严重损伤诱导的各种形式的调节性细胞死亡(RCD)释放的损伤相关分子模式(DAMP)驱动的。为了为本综述奠定坚实基础,本综述将 RCD 和 DAMP 作为生物标志物和治疗靶点,研究其在常温区域灌注(NRP)和常温机器灌注(NMP)中改善器官移植结局的作用,文中介绍了 DAMP 的性质、分类和功能,以及 RCD 途径的信号传导机制,包括铁死亡、坏死性凋亡、细胞焦亡和中性粒细胞胞外陷阱形成。随后,全面讨论了供体或供体器官的主要损伤时期,这些时期与 RCD 和 DAMP 的诱导相关,并在受体先天性同种异体免疫反应开始之前出现。供体器官的这些损伤时期包括与脑死亡后捐赠(DBD)和循环死亡后捐赠(DCD)相关的情况。本次讨论特别强调了 DBD 和 DCD 中与 RCD 相关的 DAMP 的不同来源,以及它们在循环系统中到达潜在同种异体移植物所使用的不同途径。综述最后讨论了供体器官另一个特别关键的损伤时期:植入受体后的缺血再灌注——这是决定移植结局的决定性因素。在此,讨论的重点是缺血诱导的氧化损伤机制,该机制导致 RCD 并产生 DAMP,从而引发强烈的先天性同种异体免疫反应。